CVRx | Barostim

CVRx® develops Barostim™ Baroreflex Activation Therapy (BAT), a novel therapy that activates the autonomic nervous system through baroreceptor stimulation to improve the symptoms of heart failure.

Learn more by visiting the following link cvrx.com


 

Long-Term Results of the BeAT-HF Clinical Study

130 views
April 24, 2024

Dr. Lindenfeld reviews clinical evidence from the post-market phase of the BeAT-HF trial.

Comments 0
Login to view comments. Click here to Login